Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 1
2007 1
2008 1
2009 1
2010 3
2011 6
2012 10
2013 6
2014 11
2015 4
2016 11
2017 14
2018 11
2019 17
2020 10
2021 18
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Theranostics in immuno-oncology using nanobody derivatives.
Lecocq Q, De Vlaeminck Y, Hanssens H, D'Huyvetter M, Raes G, Goyvaerts C, Keyaerts M, Devoogdt N, Breckpot K. Lecocq Q, et al. Among authors: devoogdt n. Theranostics. 2019 Oct 15;9(25):7772-7791. doi: 10.7150/thno.34941. eCollection 2019. Theranostics. 2019. PMID: 31695800 Free PMC article. Review.
Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.
Keyaerts M, Xavier C, Heemskerk J, Devoogdt N, Everaert H, Ackaert C, Vanhoeij M, Duhoux FP, Gevaert T, Simon P, Schallier D, Fontaine C, Vaneycken I, Vanhove C, De Greve J, Lamote J, Caveliers V, Lahoutte T. Keyaerts M, et al. Among authors: devoogdt n. J Nucl Med. 2016 Jan;57(1):27-33. doi: 10.2967/jnumed.115.162024. Epub 2015 Oct 8. J Nucl Med. 2016. PMID: 26449837 Free article. Clinical Trial.
Non-canonical roles of connexins.
Van Campenhout R, Cooreman A, Leroy K, Rusiecka OM, Van Brantegem P, Annaert P, Muyldermans S, Devoogdt N, Cogliati B, Kwak BR, Vinken M. Van Campenhout R, et al. Among authors: devoogdt n. Prog Biophys Mol Biol. 2020 Jul;153:35-41. doi: 10.1016/j.pbiomolbio.2020.03.002. Epub 2020 Mar 24. Prog Biophys Mol Biol. 2020. PMID: 32220599 Review.
Immuno-imaging using nanobodies.
Vaneycken I, D'huyvetter M, Hernot S, De Vos J, Xavier C, Devoogdt N, Caveliers V, Lahoutte T. Vaneycken I, et al. Among authors: devoogdt n. Curr Opin Biotechnol. 2011 Dec;22(6):877-81. doi: 10.1016/j.copbio.2011.06.009. Epub 2011 Jul 2. Curr Opin Biotechnol. 2011. PMID: 21726996 Review.
Immunogenicity Risk Profile of Nanobodies.
Ackaert C, Smiejkowska N, Xavier C, Sterckx YGJ, Denies S, Stijlemans B, Elkrim Y, Devoogdt N, Caveliers V, Lahoutte T, Muyldermans S, Breckpot K, Keyaerts M. Ackaert C, et al. Among authors: devoogdt n. Front Immunol. 2021 Mar 9;12:632687. doi: 10.3389/fimmu.2021.632687. eCollection 2021. Front Immunol. 2021. PMID: 33767701 Free PMC article.
Mechanisms Underlying Connexin Hemichannel Activation in Disease.
Van Campenhout R, Gomes AR, De Groof TWM, Muyldermans S, Devoogdt N, Vinken M. Van Campenhout R, et al. Among authors: devoogdt n. Int J Mol Sci. 2021 Mar 28;22(7):3503. doi: 10.3390/ijms22073503. Int J Mol Sci. 2021. PMID: 33800706 Free PMC article. Review.
Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy.
Barca C, Griessinger CM, Faust A, Depke D, Essler M, Windhorst AD, Devoogdt N, Brindle KM, Schäfers M, Zinnhardt B, Jacobs AH. Barca C, et al. Among authors: devoogdt n. Pharmaceuticals (Basel). 2021 Dec 22;15(1):13. doi: 10.3390/ph15010013. Pharmaceuticals (Basel). 2021. PMID: 35056071 Free PMC article. Review.
Direct Immobilization of Engineered Nanobodies on Gold Sensors.
Simões B, Guedens WJ, Keene C, Kubiak-Ossowska K, Mulheran P, Kotowska AM, Scurr DJ, Alexander MR, Broisat A, Johnson S, Muyldermans S, Devoogdt N, Adriaensens P, Mendes PM. Simões B, et al. Among authors: devoogdt n. ACS Appl Mater Interfaces. 2021 Apr 21;13(15):17353-17360. doi: 10.1021/acsami.1c02280. Epub 2021 Apr 12. ACS Appl Mater Interfaces. 2021. PMID: 33845569 Free PMC article.
117 results